164 related articles for article (PubMed ID: 27309188)
21. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
22. [Type 1 carcinoids and ECL-cell hyperplasia of the gastric mucosa].
Stachura T; Strzałka M; Bolt L
Przegl Lek; 2003; 60(12):782-8. PubMed ID: 15058016
[TBL] [Abstract][Full Text] [Related]
23. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.
Havu N
Digestion; 1986; 35 Suppl 1():42-55. PubMed ID: 3792671
[TBL] [Abstract][Full Text] [Related]
24. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.
Srivastava A; Kamath A; Barry SA; Dayal Y
Endocr Pathol; 2004; 15(1):47-54. PubMed ID: 15067176
[TBL] [Abstract][Full Text] [Related]
26. Endocrine tumours of the stomach.
Delle Fave G; Capurso G; Milione M; Panzuto F
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
[TBL] [Abstract][Full Text] [Related]
27. Gastric carcinoids: between underestimation and overtreatment.
Massironi S; Sciola V; Spampatti MP; Peracchi M; Conte D
World J Gastroenterol; 2009 May; 15(18):2177-83. PubMed ID: 19437556
[TBL] [Abstract][Full Text] [Related]
28. The role of gastric resection in the management of multicentric argyrophil gastric carcinoids.
Wängberg B; Grimelius L; Granérus G; Conradi N; Jansson S; Ahlman H
Surgery; 1990 Nov; 108(5):851-7. PubMed ID: 2237765
[TBL] [Abstract][Full Text] [Related]
29. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL
Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408
[TBL] [Abstract][Full Text] [Related]
30. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit.
Fossmark R; Calvete O; Mjønes P; Benitez J; Waldum HL
APMIS; 2016 Jul; 124(7):561-6. PubMed ID: 27150581
[TBL] [Abstract][Full Text] [Related]
31. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
[TBL] [Abstract][Full Text] [Related]
32. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
33. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.
Borch K; Ahrén B; Ahlman H; Falkmer S; Granérus G; Grimelius L
Ann Surg; 2005 Jul; 242(1):64-73. PubMed ID: 15973103
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth.
Ferraro G; Annibale B; Marignani M; Azzoni C; D'Adda T; D'Ambra G; Bordi C; delle Fave G
J Clin Endocrinol Metab; 1996 Feb; 81(2):677-83. PubMed ID: 8636288
[TBL] [Abstract][Full Text] [Related]
35. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
36. Metastatic carcinoid tumor: changing patterns of care over two decades.
Townsend A; Price T; Yeend S; Pittman K; Patterson K; Luke C
J Clin Gastroenterol; 2010 Mar; 44(3):195-9. PubMed ID: 19609217
[TBL] [Abstract][Full Text] [Related]
37. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.
Eckhauser FE; Lloyd RV; Thompson NW; Raper SE; Vinik AI
Surgery; 1988 Dec; 104(6):1046-53. PubMed ID: 3194832
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis.
Kalkan Ç; Karakaya F; Soykan İ
Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542
[TBL] [Abstract][Full Text] [Related]
39. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.
Jung JH; Choi KD; Koh YW; Park YS; Jung HY; Lee GH; Song HJ; Kim DH; Choi KS; Lee JH; Ahn JY; Kim MY; Bae SE; Kim JH
Hepatogastroenterology; 2015; 62(137):207-13. PubMed ID: 25993755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
